About

Who We Are

AggreDyne is a rapidly growing medical diagnostic company, whose focus is to develop best-in-class medical diagnostic tools that enable physicians and improve the patient experience.

What We Do

The AggreDyne system enhances patient care by producing immediate clinically relevant information, allowing providers to make informed decisions on platelet therapy. The AggreDyne systems are in-vitro diagnostic tests that measure platelet dysfunction and how well the patient is responding to antiplatelet therapy.
Patient response to antiplatelet agents varies, and poor response may be associated with increased risk of ischemic events. Monitoring antiplatelet therapy with PFT allows providers to treat patients with the safest therapy that provides the desired effect.

 

 

 

 

Our Team

 

 

ROBERT C. HUX

President/CEO

Mr. Hux has extensive experience in finance, especially as a turnaround specialist. Early in his career, he was an auditor at Ernst & Young. He was the founding CEO and Director for HEI Corp., a public company that began with two hospitals in bankruptcy that he turned around, grew to six hospitals, and sold to what is now HCA. He has also led turnarounds in the transportation and medical publishing business, and has started-up an oil and gas machining business along with numerous other start-ups including Blockbuster Video, which he and others later sold to Viacom. He has served as a court appointed trustee for multiple Cullen Trusts for twenty years.


PHIL SPEROS, PHD

Chief Operating Officer

Dr. Speros has twenty-five years experience in technology commercialization in the context of entrepreneurial business ventures and consulting. His participation in product development teams has extended from conceiving new products to testing, commercial design, start-up launch and implementation of strategic marketing plans. He has been partner, supplier or customer to small and emerging companies and large corporations. His technical experience includes scientific instrument technologies including rapid kinetics, spectroscopy and polarimetry, thermal management, data acquisition, processing and analysis, and other aspects of technical product development. He has assembled highly qualified scientific and technical teams in support of biotech, instrumentation, and data-based product innovations. Dr. Speros has instructed college and post-graduate students in various courses and capacities since 1983. His PhD in Biochemistry is from The Johns Hopkins University and his MBA from the McCombs School of University of Texas at Austin. He holds four US patents and is the author of several scientific publications.


ANDREW YEE

Vice President Of Operations & Engineering

Andrew Yee is the Director of Operations and Engineering. He is an experienced medical device development professional with over 25 years of direct experience in the research, development, new product introduction and manufacturing of medical products. These products have served globally in areas such as interventional cardiology, medical imaging, women’s health, mass market retail consumer medical devices and over the counter cosmetics. Management of high reliability as well as high volume global medical product development, multi-national manufacturing and international logistics have been the most recent focus of his career.

He received a Master’s degree in Biomedical Engineering and an MBA from Texas A&M university. He has also earned a Bachelor degree in Electrical Engineering from Northwestern University. In addition to AggreDyne, he has also served the community as an Assistant EMS Chief and EMT for the Friendswood Volunteer Fire Department for over 20 years. He is also a volunteer on the Safety Committee at the Houston.


JEFFERY R DAHLEN, PHD

Advisor, Clinical and Scientific Affairs

Dr. Dahlen has more than 15 years of experience in the IVD industry and has held leadership positions in worldwide clinical, medical, and regulatory affairs, as well as marker discovery and assay development at Biosite, Oculir, and Accumetrics, where he served most recently as Chief Scientific Officer. He has led collaborations and clinical trials that have been published in several prominent journals such as New England Journal of Medicine and JAMA. Dr. Dahlen received a Ph.D. in Biomedical Sciences (Biochemistry, Molecular Biology, and Pathology) from the University of New Mexico and a Bachelor’s degree in Engineering (Theoretical & Applied Mechanics) from the University of Illinois.


Board of Directors

 

 

BRADY F. CARRUTH,

CHAIRMAN

Brady Carruth has extensive business experience in acquiring and operating several distribution and service businesses in the Houston area. He has served on the boards of directors of two NYSE-listed companies, including American General Corp. until its merger with American Intl. Group in August 2001.

Mr. Carruth, a native Houstonian, earned his MBA with a concentration in finance and insurance from the University of Texas at Austin. Active in several Houston-community civic and cultural endeavors, he serves as president of the Wortham Foundation, one of Houston’s largest philanthropic institutions.

In 2002, he acquired London American Risk Specialists, Inc. IMS Insurance Market Solutions acquired London American in 2010, creating IMS/London American, one of the largest independent multi-line managing general agencies in the Southwest. Mr. Carruth continues as a director and equity participant.


EDGAR C. “RED” GRIFFIN

Red Griffin turned his early work as an oilfield roughneck and commercial power salesman (plus studies at the University of Texas and the University of Houston leading to a marketing degree) into a career in entrepreneurship.

He started as an independent broker of barges and towboats, and then formed Coastal Towing as president and chairman of the board. Mr. Griffin grew Coastal from six tank barges and three towboats to 136 tank barges and 36 towboats. When he sold the company in 2001, Coastal Towing was the largest transporter by barge of heavy liquid fuel oil on the inland waterways of the United States.

In 2001, Mr. Griffin formed Grifco Transportation, Ltd. He built the company in less than eight years to 20 tank barges and 10 towboats. He sold Grifco in 2008 for $125 million to Genesis Energy Partners, a NYSE-traded company.

Meanwhile, he served on the boards of directors of two banks. He is a lifetime vice president and director of the Houston Livestock Show and Rodeo, where he continues to be active. Additionally, he has served, and continues to serve, on the boards of several local charities.


ROBERT C. HUX

Mr. Hux has extensive experience in finance, especially as a turnaround specialist. Early in his career, he was an auditor at Ernst & Young. He was the founding CEO and Director for HEI Corp., a public company that began with two hospitals in bankruptcy that he turned around, grew to six hospitals, and sold to what is now HCA. He has also led turnarounds in the transportation and medical publishing business, and has started-up an oil and gas machining business along with numerous other start-ups including Blockbuster Video, which he and others later sold to Viacom. He has served as a court appointed trustee for multiple Cullen Trusts for twenty years.


SARA OSTROFSKY

Sara Ostrofsky graduated from the University of Texas in Austin. Since then she has been active in the publishing of various trade publication in the telecommunications in-dustry. She has also been involved with the deregulation of the pay telephone, pre-paid phone cards and the start of voice technology. She is an owner/investor/mentor in many startup companies in the beauty and movie industries. Ms. Ostrofsky is also active and several charities in the Houston community.


DENNIS STEGER

Dennis Steger is the founder of three major shipyard facilities, and a medical clinic in the Houston area. He served as the Chairman for the Shipyard Council of America from 1996-1997. He had also served as the Chairman and Director of Lone Star Bank from 1992 – 1998, and was a catalyst in its merger with Sterling Bank in 1998. Mr. Steger graduated from Murray State University in Kentucky. He has always been an active participant in the Houston community. He has been a Director of the Houston Livestock Show & Rodeo since 2004, and a Vice President since 2013. He has served as a Director for the City of La Porte Water Authority since 2004, and is a member of the 20 Year Planning committee for the City of La Porte.


SIVAPRASAD SUKAVANESVAR, PHD

Dr. Sukavaneshvar has deep expertise in the fields of platelet/thrombosis/hemocompatibility. His experience is supplemented with an engineering background and device design experience. He is extensively published and is well recognized in his field. He was instrumental in developing the AggreGuide technology and brings extensive critical knowledge of the AggreGuide’s nuances to the Company. He will advise and guide AggreDyne’s technological development program while maintaining his full time position as a Vice President of Thrombodyne.


 
 
error: